v3.23.3
Condensed Consolidated Statements of Cash Flows (Unaudited)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
USD ($)
Sep. 30, 2023
USD ($)
Sep. 30, 2022
USD ($)
Operating activities:      
Net loss $ (34,908) $ (69,048) $ (20,988)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:      
Depreciation 1,357 4,302 3,961
Amortization of right-of-use assets   3,647 3,618
Stock-based compensation 2,283 7,808 11,600
Provision (recovery) for credit losses   0 (307)
Equity securities earned from research and development activities ($0 and $1,245 from a related party)   187 1,245
Unrealized gain on non-marketable securities   0 208
Asset impairment and other charges 9,984 9,984 0
Impairment of investment in non-marketable equity securities 3,900 3,875 0
Other non-cash items   (3) (29)
Changes in operating assets and liabilities:      
Financial assets   21,580 8,184
Inventories   (276) (463)
Prepaid expenses and other assets   (252) 429
Accounts payable   (105) (351)
Accrued compensation and other accrued liabilities   (7,269) 2,279
Other long-term liabilities   (4,384) (3,863)
Deferred revenue   (11,273) 3,750
Net cash provided by (used in) operating activities   (41,601) 6,367
Investing activities:      
Purchase of property and equipment   (4,798) (8,340)
Proceeds from sale of property and equipment   27 29
Investment in non-marketable securities   (1,191) (5,300)
Net cash used in investing activities   (5,962) (13,611)
Financing activities:      
Proceeds from exercises of stock options   422 612
Proceeds from issuance of common stock in connection with public offering   8,652 0
Costs incurred in connection with issuance of common stock at public offering   (503) (42)
Taxes paid related to net share settlement of equity awards   (404) (1,484)
Net cash provided by (used in) financing activities   8,167 (914)
Net decrease in cash, cash equivalents and restricted cash   (39,396) (8,158)
Cash, cash equivalents and restricted cash at the beginning of the period   116,026 118,895
Cash, cash equivalents and restricted cash at the end of the period 76,630 76,630 110,737
Supplemental disclosure of cash flow information:      
Interest paid   28 22
Income taxes paid   193 100
Supplemental non-cash investing and financing activities:      
Capital expenditures incurred but not yet paid   159 128
Cash reconciliation:      
Cash and cash equivalents 74,577 74,577 108,689
Restricted cash, current and non-current 2,053 2,053 2,048
Total cash, cash equivalents and restricted cash $ 76,630 $ 76,630 $ 110,737

Source